A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition

Molecular and Cellular Biology

Volumn 31, Issue 19, 2011, Pages 4036-4051

  Kumar, Sanjeev ^a   Park, Sun Hee ^a   Cieply, Benjamin ^a   Schupp, Jane ^a   Killiam, Elizabeth ^b   Zhang, Fan ^c   Rimm, David L ^b   Frisch, Steven M ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MELANOMA ANTIGEN; NEUROTROPHIN RECEPTOR; T BOX TRANSCRIPTION FACTOR; UVOMORULIN;

ANIMAL CELL; ANOIKIS; ARTICLE; CANCER INHIBITION; CELL PROTECTION; CYTOPLASM; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANKYRINS; ANOIKIS; ANTIGENS, NEOPLASM; CADHERINS; CELL LINE, TUMOR; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICE; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 80053578949     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01342-10     Document Type: Article

References (104)

1. Ayyanathan, K., et al. 2007. The Ajuba LIM domain protein is a corepressor for SNAG domain mediated repression and participates in nucleocytoplasmic shuttling. Cancer Res. 67:9097-9106.
2. Barker, P. A., and A. Salehi. 2002. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J. Neurosci. Res. 67:705-712.
3. Barrallo-Gimeno, A., and M. A. Nieto. 2005. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132:3151-3161.
4. Bartel, P. L., and S. Fields. 1995. Analyzing protein-protein interactions using two-hybrid system. Methods Enzymol. 254:241-263.
5. Bertrand, M. J., et al. 2008. NRAGE, a p75NTR adaptor protein, is required for developmental apoptosis in vivo. Cell Death Differ. 15:1921-1929.
6. Bhattacharjee, A., et al. 2001. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U. S. A. 98:13790-13795.
7. Boer, J. M., et al. 2001. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res. 11:1861-1870.
8. Camp, R. L., G. G. Chung, and D. L. Rimm. 2002. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat. Med. 8:1323-1327.
9. Carlson, H., S. Ota, C. E. Campbell, and P. J. Hurlin. 2001. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Hum. Mol. Genet. 10:2403-2413.
10. Carlson, H., S. Ota, Y. Song, Y. Chen, and P. J. Hurlin. 2002. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene 21:3827-3835.
11. Chen, C. H., et al. 1999. Nuclear trafficking of cubitus interruptus in the transcriptional regulation of Hedgehog target gene expression. Cell 98:305- 316.
12. Chen, R. H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of Erk- and Rsk-encoded protein kinases. Mol. Cell. Biol. 12: 915-927.
13. Cheng, H., et al. 2009. SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci. Signal. 2:ra35.
14. Chinnadurai, G. 2009. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res. 69:731-734.
15. Chomez, P., et al. 2001. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61:5544-5551.
16. Chu, C. S., et al. 2007. NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo. Cancer Lett. 250:268-275.
17. Davis, E., et al. 2008. Ectopic Tbx2 expression results in polyploidy and cisplatin resistance. Oncogene 27:976-984.
18. Debnath, J., S. K. Muthuswamy, and J. S. Brugge. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 30:256-268.
19. Derksen, P. W., et al. 2006. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10:437-449.
20. Di Certo, M. G., et al. 2007. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J. Cell Sci. 120:1852-1858.
21. Du, Q., Y. Zhang, X. X. Tian, Y. Li, and W. G. Fang. 2009. MAGE-D1 inhibits proliferation, migration, and invasion of human breast cancer cells. Oncol. Rep. 22:659-665.
22. Eberhard, D. A., L. R. Karns, S. R. VandenBerg, and C. E. Creutz. 2001. Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J. Cell Sci. 114:3155-3166.
23. Eccles, S. A., and D. R. Welch. 2007. Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742-1757.
24. Eischen, C. M., J. R. Alt, and P. Wang. 2004. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development. Oncogene 23:8931-8940.
25. Evan, G. I., and D. C. Hancock. 1985. Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell 43:253-261.
26. Formstecher, E., et al. 2005. Protein interaction mapping: a Drosophila case study. Genome Res. 15:376-384.
27. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
28. Frisch, S. M., and R. A. Screaton. 2001. Anoikis mechanisms. Curr. Opin. Cell Biol. 13:555-562.
29. Fromont-Racine, M., J. C. Rain, and P. Legrain. 1997. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet. 16:277-282.
30. Gassmann, P., and J. Haier. 2008. The tumor cell-host organ interface in the early onset of metastatic organ colonization. Clin. Exp. Metastasis 25:171-181.
31. Geiger, T. R., and D. S. Peeper. 2009. Metastasis mechanisms. Biochim. Biophys. Acta 1796:293-308.
32. Gilmore, A. P. 2005. Anoikis. Cell Death Differ. 12(Suppl. 2):1473-1477.
33. Ginos, M. A., et al. 2004. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 64:55-63.
34. Glinsky, G. V., O. Berezovska, and A. B. Glinskii. 2005. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115:1503-1521.
35. Goyal, P., D. Pandey, A. Behring, and W. Siess. 2005. Inhibition of nuclear import of LIMK2 in endothelial cells by protein kinase C-dependent phosphorylation at Ser-283. J. Biol. Chem. 280:27569-27577.
36. Groeper, C., et al. 2007. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non-small-cell lung cancer. Int. J. Cancer 120:337-343.
37. Grooteclaes, M., et al. 2003. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc. Natl. Acad. Sci. U. S. A. 100:4568-4573.
38. Harada, O., et al. 2007. The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer. Int. J. Cancer 121:1072-1078.
39. Hennessy, B. T., et al. 2009. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69:4116-4124.
40. Hewitt, C., et al. 2002. Germline mutation of ARF in a melanoma kindred. Hum. Mol. Genet. 11:1273-1279.
41. Ikeda, K., et al. 2008. Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity. Exp. Cell Res. 314:3392-3404.
42. Ismail, A., and A. Bateman. 2009. Expression of TBX2 promotes anchorage-independent growth and survival in the p53-negative SW13 adrenocortical carcinoma. Cancer Lett. 278:230-240.
43. Itahana, K., and Y. Zhang. 2008. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 13:542-553.
44. Ivanova, N., et al. 2006. Dissecting self-renewal in stem cells with RNA interference. Nature 442:533-538.
45. Jacobs, J. J., et al. 2000. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nat. Genet. 26:291-299.
46. Kalluri, R., and R. A. Weinberg. 2009. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119:1420-1428.
47. Kamb, A., et al. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
48. Kanungo, J., S. J. Pratt, H. Marie, and G. D. Longmore. 2000. Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. Mol. Biol. Cell 11:3299-3313.
49. Kim, W. Y., and N. E. Sharpless. 2006. The regulation of INK4/ARF in cancer and aging. Cell 127:265-275.
50. Kizhatil, K., et al. 2007. Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J. Biol. Chem. 282:26552-26561.
51. Klymkowsky, M. W., and P. Savagner. 2009. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 174:1588-1593.
52. Krimpenfort, P., K. C. Quon, W. J. Mooi, A. Loonstra, and A. Berns. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413:83-86.
53. Kurrey, N. K., et al. 2009. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27:2059-2068.
54. Lee, J. M., S. Dedhar, R. Kalluri, and E. W. Thompson. 2006. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172:973-981.
55. Li, H., et al. 2009. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460:1136-1139.
56. Lin, X., et al. 2003. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol. Cell 11:1389-1396.
57. Lingbeek, M. E., J. J. Jacobs, and M. van Lohuizen. 2002. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J. Biol. Chem. 277:26120-26127.
58. Maestro, R., et al. 1999. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13:2207-2217.
59. Mahlamaki, E. H., et al. 2002. Frequent amplification of 8q24-, 11q-, 17q-, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35:353-358.
60. Mani, S. A., et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
61. Mayer, B. J., H. Hirai, and R. Sakai. 1995. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5:296-305.
62. Moreno-Miralles, I., et al. 2005. The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia. J. Biol. Chem. 280:40097-40103.
63. Morgan, M., J. Thorburn, P. P. Pandolfi, and A. Thorburn. 2002. Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J. Cell Biol. 157:975-984.
64. Navarro, C., et al. 2005. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 24:4330-4339.
65. Nelson, W. J., E. M. Shore, A. Z. Wang, and R. W. Hammerton. 1990. Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney epithelial cells. J. Cell Biol. 110:349-357.
66. Neve, R. M., et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527.
67. Niwa, H., K. Ogawa, D. Shimosato, and K. Adachi. 2009. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460:118-122.
68. Onder, T. T., et al. 2008. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68:3645-3654.
69. Paine, P. L., C. F. Austerberry, L. J. Desjarlais, and S. B. Horowitz. 1983. Protein loss during nuclear isolation. J. Cell Biol. 97:1240-1242.
70. Paliwal, S., et al. 2006. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol. Cell. Biol. 26:2360-2372.
71. Paxton, C., H. Zhao, Y. Chin, K. Langner, and J. Reecy. 2002. Murine Tbx2 contains domains that activate and repress gene transcription. Gene 283: 117-124.
72. Pickard, B. W., A. B. Hodsman, L. J. Fraher, and P. H. Watson. 2007. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-α/β and chromosomal region maintenance 1/exportin 1. Endocrinology 148:2282-2289.
73. Pradhan, D., C. R. Lombardo, S. Roe, D. L. Rimm, and J. S. Morrow. 2001. -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo. J. Biol. Chem. 276:4175-4181.
74. Prince, S., S. Carreira, K. W. Vance, A. Abrahams, and C. R. Goding. 2004. Tbx2 directly represses the expression of the p21WAF1 cyclin-dependent kinase inhibitor. Cancer Res. 64:1669-1674.
75. Puisieux, A., S. Valsesia-Wittmann, and S. Ansieau. 2006. A twist for survival and cancer progression. Br. J. Cancer 94:13-17.
76. Reddig, P. J., and R. L. Juliano. 2005. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24:425-439.
77. Reddy, E. M., S. T. Chettiar, N. Kaur, V. Shepal, and A. Shiras. Dlxin-1, a MAGE family protein, induces accelerated neurite outgrowth and cell survival by enhanced and early activation of MEK and Akt signaling pathways in PC12 cells. Exp. Cell Res. 316:2220-2236.
78. Redmond, K. L., et al. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells. Oncogene 29:3252-3262.
79. Robertson, K. D., and P. A. Jones. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and downregulated by wild-type p53. Mol. Cell. Biol. 18:6457-6473.
80. Rodriguez, M., E. Aladowicz, L. Lanfrancone, and C. R. Goding. 2008. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res. 68:7872-7881.
81. Rowley, M., E. Grothey, and F. J. Couch. 2004. The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J. Mammary Gland Biol. Neoplasia 9:109-118.
82. Salehi, A. H., et al. 2000. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27:279-288.
83. Sasaki, A., L. Hinck, and K. Watanabe. 2005. RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins. J. Recept. Signal. Transduct. Res. 25:181-198.
84. Sasaki, A., Y. Masuda, K. Iwai, K. Ikeda, and K. Watanabe. 2002. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J. Biol. Chem. 277:22541-22546.
85. Sayan, A. E., et al. 2009. SIP1 protein protects cells from DNA damageinduced apoptosis and has independent prognostic value in bladder cancer. Proc. Natl. Acad. Sci. U. S. A. 106:14884-14889.
86. Sherr, C. J., et al. 2005. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harbor Symp. Quant. Biol. 70:129-137.
87. Simpson, C. D., K. Anyiwe, and A. D. Schimmer. 2008. Anoikis resistance and tumor metastasis. Cancer Lett. 272:177-185.
88. Singh, A., and J. Settleman. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29:4741-4751.
89. Smit, M. A., T. R. Geiger, J. Y. Song, I. Gitelman, and D. S. Peeper. 2009. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol. Cell. Biol. 29:3722-3737.
90. Taube, J. H., et al. Core epithelial-to-mesenchymal transition interactome gene expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. U. S. A. 107:15449-15454.
91. Thiery, J. P., H. Acloque, R. Y. Huang, and M. A. Nieto. 2009. Epithelialmesenchymal transitions in development and disease. Cell 139:871-890.
92. Valsesia-Wittmann, S., et al. 2004. Oncogenic cooperation between HTwist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6:625-630.
93. Vance, K. W., S. Carreira, G. Brosch, and C. R. Goding. 2005. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65:2260-2268.
94. Vandewalle, C., F. Van Roy, and G. Berx. 2009. The role of the ZEB family of transcription factors in development and disease. Cell Mol. Life Sci. 66:773-787.
95. Vojtek, A. B., and S. M. Hollenberg. 1995. Ras-Raf interaction: two-hybrid analysis. Methods Enzymol. 255:331-342.
96. Vormer, T. L., F. Foijer, C. L. Wielders, and H. te Riele. 2008. Anchorageindependent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2. Mol. Cell. Biol. 28:7263-7273.
97. Wang, C., et al. 2005. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 24:3279-3290.
98. Wang, C., F. J. Rauscher III, W. D. Cress, and J. Chen. 2007. Regulation of E2F1 function by the nuclear corepressor KAP1. J. Biol. Chem. 282: 29902-29909.
99. Wang, R., et al. 2009. Autoinhibition of UNC5b revealed by the cytoplasmic domain structure of the receptor. Mol. Cell 33:692-703.
100. Wardle, F. C., and V. E. Papaioannou. 2008. Teasing out T-box targets in early mesoderm. Curr. Opin. Genet. Dev. 18:418-425.
101. Williams, M. E., P. Strickland, K. Watanabe, and L. Hinck. 2003. UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE. J. Biol. Chem. 278:17483-17490.
102. Yang, B., et al. 2007. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGEpositive cell lines. Cancer Res. 67:9954-9962.
103. Zavadil, J., J. Haley, R. Kalluri, S. K. Muthuswamy, and E. Thompson. 2008. Epithelial-mesenchymal transition. Cancer Res. 68:9574-9577.
104. Zhan, L., et al. 2008. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135:865-878.